XENE vs ABBV

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 02, 2026

XENE

53.4
AI Score
VS
XENE Wins

ABBV

52.4
AI Score

Investment Advisor Scores

XENE

53score
Recommendation
HOLD

ABBV

52score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric XENE ABBV Winner
Revenue 264,000 8.24B ABBV
Net Income -22.64M 2.75B ABBV
Net Margin -8575.4% 33.4% ABBV
Operating Income -24.52M 8.82B ABBV
ROE -52.3% -94.0% XENE
ROA -48.8% 4.2% ABBV
Total Assets 46.36M 66.16B ABBV
Cash 14.69M 8.02B ABBV
Free Cash Flow -22.14M 9.52B ABBV

Relative Price Performance (Last 90 Days)

XENE 1M: +3.9% · 3M: +11.8% ABBV 1M: 0.0% · 3M: +18.7%

Current Technical Phase

XENE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 47

RSI (14): 47.4 · Price: $62.67

ABBV

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (8.9% over 20 days), RSI 51

RSI (14): 51.2 · Price: $250.94

Fundamentals Snapshot

Metric XENE ABBV
Market Cap
Forward P/E -12.8 15.4
Trailing P/E 130.0
Revenue (TTM)
Revenue Growth -1.0% 0.1%
Gross Margin 0.7%
Operating Margin 0.0% 0.3%
EPS -4.57 1.98
Dividend Yield 0.03%

Frequently Asked Questions

Based on our detailed analysis, XENE is currently the stronger investment candidate, winning 1 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.